Quest Diagnostics, a leading provider of diagnostic testing, is set to release its Q3 2024 earnings report on October 22nd. Analysts anticipate strong results with an EPS of $2.27, and investors will be keen to see if the company surpasses estimates and provides positive guidance for the upcoming quarter. This article provides an in-depth analysis of Quest Diagnostics’s historical performance, analyst sentiment, and peer comparisons, offering insights for investors ahead of the earnings release.